| Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease M Mota, BA Banini, SC Cazanave, AJ Sanyal Metabolism 65 (8), 1049-1061, 2016 | 504 | 2016 |
| A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer A Asgharpour, SC Cazanave, T Pacana, M Seneshaw, R Vincent, ... Journal of hepatology 65 (3), 579-588, 2016 | 490 | 2016 |
| Current and future pharmacologic treatment of nonalcoholic steatohepatitis BA Banini, AJ Sanyal Current opinion in gastroenterology 33 (3), 134-141, 2017 | 70 | 2017 |
| Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling I Nakamura, K Zakharia, BA Banini, DS Mikhail, TH Kim, JD Yang, ... PloS one 9 (4), e92273, 2014 | 69 | 2014 |
| Updates on chronic HBV: current challenges and future goals HM Lee, BA Banini Current treatment options in gastroenterology 17, 271-291, 2019 | 68 | 2019 |
| Transcriptional induction of periostin by a sulfatase 2–TGFβ1–SMAD signaling axis mediates tumor angiogenesis in hepatocellular carcinoma G Chen, I Nakamura, R Dhanasekaran, E Iguchi, EJ Tolosa, PA Romecin, ... Cancer research 77 (3), 632-645, 2017 | 66 | 2017 |
| Transcriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulators MA Keller, S Addya, R Vadigepalli, B Banini, K Delgrosso, H Huang, ... Physiological genomics 28 (1), 114-128, 2006 | 65 | 2006 |
| Multidisciplinary management of hepatic hydrothorax in 2020: an evidence‐based review and guidance BA Banini, Y Alwatari, M Stovall, N Ogden, E Gershman, RD Shah, ... Hepatology 72 (5), 1851-1863, 2020 | 62 | 2020 |
| The transcriptomic signature of disease development and progression of nonalcoholic fatty liver disease S Cazanave, A Podtelezhnikov, K Jensen, M Seneshaw, DP Kumar, ... Scientific reports 7 (1), 17193, 2017 | 60 | 2017 |
| Nonalcoholic fatty liver disease: epidemiology, pathogenesis, natural history, diagnosis, and current treatment options BA Banini, AJ Sanyal Clinical Medicine Insights: Therapeutics 8, CMT. S18885, 2016 | 58 | 2016 |
| Identification of a metabolic, transcriptomic, and molecular signature of patatin‐like phospholipase domain containing 3–mediated acceleration of steatohepatitis BA Banini, DP Kumar, S Cazanave, M Seneshaw, F Mirshahi, ... Hepatology 73 (4), 1290-1306, 2021 | 31 | 2021 |
| The use of cell free DNA in the diagnosis of HCC BA Banini, AJ Sanyal Hepatoma research 5, 2019 | 23 | 2019 |
| Haptoglobin 2 allele is associated with histologic response to vitamin E in subjects with nonalcoholic steatohepatitis BA Banini, SC Cazanave, KP Yates, A Asgharpour, R Vincent, F Mirshahi, ... Journal of clinical gastroenterology 53 (10), 750-758, 2019 | 17 | 2019 |
| NAFLD-related HCC BA Banini, AJ Sanyal Advances in Cancer Research 149, 143-169, 2021 | 14 | 2021 |
| The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex RM Carr, PAR Duran, EJ Tolosa, C Ma, AM Oseini, CD Moser, BA Banini, ... Journal of Biological Chemistry 295 (9), 2698-2712, 2020 | 14 | 2020 |
| Nonalcoholic Steatohepatitis (NASH) Has Surpassed Hepatitis C as the Leading Etiology for Listing for Liver Transplant: Implications for NASH in Children and Young Adults: 755 BA Banini, M Mota, M Behnke, A Sharma, AJ Sanyal Official journal of the American College of Gastroenterology| ACG 111, S339, 2016 | 11 | 2016 |
| Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis JJ Beaudoin, T Liang, Q Tang, BA Banini, VH Shah, AJ Sanyal, ... Alcoholism: Clinical and Experimental Research 45 (4), 709-719, 2021 | 9 | 2021 |
| Identification of a metabolic, transcriptomic and molecular signature of PNPLA3-mediated acceleration of steatohepatitis BA Banini, DP Kumar, S Cazanave, M Seneshaw, F Mirshahi, ... Hepatology (Baltimore, Md.), 2021 | 9 | 2021 |
| Derivation and validation of a model to predict clinically significant portal hypertension using transient elastography and FIB-4 BA Banini, S Patel, WY Jonathan, L Kang, C Bailey, BJ Strife, MS Siddiqui, ... Journal of clinical gastroenterology 57 (2), 189-197, 2023 | 8 | 2023 |
| Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling I Nakamura, K Zakharia, BA Banini, DS Mikhail, TH Kim, JD Yang, ... Plos one 10 (11), e0142355, 2015 | 7 | 2015 |
